Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage dna hdac'

Search results for: 'research area dna damage dna hdac'

Items 51-60 of 70

Page
per page
  1. FT-207 (NSC 148958)
    B1474 FT-207 (NSC 148958)
    Summary: DNA/RNA synthesis inhibitor
      ≥100 mg/mL
  2. Mizoribine
    B1472 Mizoribine
    Target: Synthases/Synthetases
    Summary: DNA/RNA synthesis inhibitor
      insoluble in EtOH; ≥88.2 mg/mL
  3. Niclosamide
    B2283 Niclosamide
    Target: STAT
    Summary: Inhibitor of the STAT3 signaling pathway
  4. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    Target: Topoisomerases
    Summary: Topoisomerase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥3.66 mg/mL
  5. Cidofovir
    A5790 Cidofovir
    Target: CMV
    Summary: Anti-CMV drug;inhibitor of viral DNA syntheis
      insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL
  6. NSC 74859
    A8338 NSC 74859
     5 Citation
    Target: STAT
    Summary: Stat3 inhibitor
      insoluble in H2O; ≥18.25 mg/mL
  7. Actinomycin D
    A4448 Actinomycin D
     15 Citation
    Summary: RNA polymerase inhibitor
      ≥62.75 mg/mL
  8. LY3023414
    B6099 LY3023414
    Target: Akt|PI3K|mTOR|DNA-PK
    Summary: class I PI3K isoforms, mTOR and DNA-PK inhibitor
      ≥40.6 mg/mL
  9. ML216
    B8015 ML216
    Target: BLM
    Summary: BLM helicase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  10. BMH-21
    B4896 BMH-21
    Target: RNA Polymerases
    Summary: RNA polymerase I Inhibitior
      insoluble in EtOH; insoluble in H2O; ≥7.4 mg/mL

Items 51-60 of 70

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 67item
  2. Natural Products 1 item
  3. Peptides 1 item
  4. Peptides & Proteins 1 item
Reversibility
  1. Reversible 4item
Target
  1. Histone Deacetylases (HDACs) 23item
  2. Akt 1 item
  3. PI3K 5item
  4. mTOR 3item
  5. AP-1 1 item
  6. Chk 2item
  7. Thymidylate Synthase 1 item
  8. Trk Receptors 1 item
  9. STAT 3item
  10. JAK 1 item
  11. DNA-PK 5item
  12. Topoisomerases 5item
  13. DNA Methyltransferases 3item
  14. Ubiquitin-specific proteases 1 item
  15. Fatty-acid-binding proteins (FABPs) 1 item
  16. ATM/ATR 2item
  17. BLM 1 item
  18. HSV 1 item
  19. Synthases/Synthetases 2item
  20. MAGL 1 item
  21. RNA Polymerases 1 item
  22. CMV 1 item
  23. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  24. Cytidine deaminases 1 item
  25. HDAC 1 item
  26. ATM 1 item
  27. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 63item
  2. Cell Experiments 41item
Related Disease
  1. Acute Myelogenous Leukemia 3item
  2. Acute Myeloid Leukemia 1 item
  3. Acute Renal Failure 1 item
  4. Bladder Cancer 2item
  5. Bladder Carcinoma 1 item
  6. Bladder Diseases 1 item
  7. Breast Cancer 18item
  8. Cancer 55item
  9. Cervical Cancer 2item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Colon Cancer 12item
  12. Colorectal Cancer 6item
  13. Dyskinesia 1 item
  14. Friedreich's Ataxia 1 item
  15. Glioblastoma 3item
  16. Glioma 2item
  17. Hepatic Cancer 1 item
  18. Hepatocellular Carcinoma 3item
  19. HIV Infections 2item
  20. Inflammatory Diseases 1 item
  21. Leukemia 4item
  22. Lung Cancer 5item
  23. Lymphoma 5item
  24. Melanoma 5item
  25. Multiple Myeloma 4item
  26. Myeloma 3item
  27. Neuroblastoma 2item
  28. Neuronal Protection 1 item
  29. Non-small Cell Lung Cancer 3item
  30. Non-small Cell Lung Carcinoma 1 item
  31. Ovarian Cancer 9item
  32. Pancreatic Cancer 3item
  33. Prostate Cancer 12item
  34. Renal Cancer 1 item
  35. Renal Cell Carcinoma 1 item
  36. Sarcoma 1 item
  37. Squamous Cell Carcinoma 1 item
  38. Testicular Cancer 2item
  39. Type 2 Diabetes 1 item